Research Method

Double-Blind Study

A research design in which neither the subjects nor the researchers assessing outcomes know which treatment condition each subject received.

Definition

A double-blind study is a controlled experimental design in which both the subjects (or animals) and the researchers assessing outcomes are kept unaware of group assignments (treatment vs. control). This blinding prevents measurement bias arising from researchers unconsciously favoring expected outcomes in their assessments and from subjects modifying their behavior based on knowledge of their treatment status. Double-blinding is most impactful in studies with subjective endpoints and is considered essential in rigorous clinical research design. In preclinical animal research, blinding of outcome assessors (even when subjects cannot be blinded) significantly reduces measurement bias.

Research Context

Double-blind design is the standard for human clinical research and is increasingly required in high-quality preclinical animal research as well. In the context of peptide research, blinding is particularly important for outcome assessments that involve subjective scoring (histological grading, behavioral assessment) where observer bias can substantially influence results. Published peptide research of highest quality reports whether and how blinding was implemented in outcome assessment.

Relevant Compounds

This term applies to the following research compound hubs.

Frequently Asked Questions

Explore the Research Library

Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.